| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $42.5M | +105.7% |
| Cost of Revenue | $22.9M | +88.1% |
| Gross Profit | $19.5M | +131.2% |
| R&D Expense | $3.7M | +47.9% |
| SG&A Expense | $14.8M | +46.2% |
| Operating Income | -$8.2M | +56.8% |
| Interest Expense | $272K | -14.4% |
| Pre-tax Income | -$8.2M | +57.4% |
| Income Tax | $4.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.2M | +587.3% |
| Accounts Receivable | $12.4M | +177.6% |
| Inventory | $17.1M | +67.2% |
| Current Assets | $48.8M | +78.0% |
| Total Assets | $74.2M | +75.1% |
| Current Liabilities | $26.2M | +23.0% |
| Total Liabilities | $36.0M | +24.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.5M | -95.1% |
| Capital Expenditures | $3.7M | +453.2% |
| Investing Cash Flow | -$3.7M | -453.2% |
| Financing Cash Flow | $26.2M | +177.6% |
| Free Cash Flow | -$22.2M | -118.4% |
| — |
| Net Income | -$12.1M | +36.7% |
| EPS (Basic) | -$0.06 | +45.5% |
| EPS (Diluted) | -$0.06 | +45.5% |
| Stockholders' Equity |
| $38.2M |
| +184.0% |